Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 12

1.

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, et al.

Nature. 1993 Jun 3;363(6428):458-60.

PMID:
8099202
2.

Frequent association between MEN 2A and cutaneous lichen amyloidosis.

Verga U, Fugazzola L, Cambiaghi S, Pritelli C, Alessi E, Cortelazzi D, Gangi E, Beck-Peccoz P.

Clin Endocrinol (Oxf). 2003 Aug;59(2):156-61.

PMID:
12864791
3.

Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations.

Pacini F, Romei C, Miccoli P, Elisei R, Molinaro E, Mancusi F, Iacconi P, Basolo F, Martino E, Pinchera A.

Surgery. 1995 Dec;118(6):1031-5.

PMID:
7491519
4.

Identification of the Cys634-->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis.

Ceccherini I, Romei C, Barone V, Pacini F, Martino E, Loviselli A, Pinchera A, Romeo G.

J Endocrinol Invest. 1994 Mar;17(3):201-4.

PMID:
7914213
5.
6.

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B.

Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, et al.

Science. 1995 Jan 20;267(5196):381-3.

PMID:
7824936
7.

Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B.

Zenaty D, Aigrain Y, Peuchmaur M, Philippe-Chomette P, Baumann C, Cornelis F, Hugot JP, Chevenne D, Barbu V, Guillausseau PJ, Schlumberger M, Carel JC, Travagli JP, Léger J.

Eur J Endocrinol. 2009 May;160(5):807-13. doi: 10.1530/EJE-08-0854. Epub 2009 Feb 24.

PMID:
19240193
8.
9.

Acceptable age for prophylactic surgery in children with multiple endocrine neoplasia type 2a.

Kahraman T, de Groot JW, Rouwe C, Hofstra RM, Links TP, Sijmons RH, Plukker JT.

Eur J Surg Oncol. 2003 May;29(4):331-5.

PMID:
12711285
10.

Pheochromocytoma penetrance varies by RET mutation in MEN 2A.

Quayle FJ, Fialkowski EA, Benveniste R, Moley JF.

Surgery. 2007 Dec;142(6):800-5; discussion 805.e1. Epub 2007 Nov 5. Erratum in: Surgery. 2008 Feb;143(2):301.

PMID:
18063059
11.

Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma.

Karga HJ, Karayianni MK, Linos DA, Tseleni SC, Karaiskos KD, Papapetrou PD.

Eur J Endocrinol. 1998 Oct;139(4):410-5.

PMID:
9820617
12.

RET oncogene mutations in medullary thyroid carcinoma in Mexican families.

González B, Salcedo M, Medrano ME, Mantilla A, Quiñónez G, Benítez-Bribiesca L, Rodríguez-Cuevas S, Cabrera L, de León B, Altamirano N, Tapia J, Dawson B.

Arch Med Res. 2003 Jan-Feb;34(1):41-9.

PMID:
12604374

Supplemental Content

Support Center